Katarina Le Blanc

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Massimo Dominici, Katarina Le Blanc, Ingo Mueller et al. · Cytotherapy · 2006 · 17.7K citations

Life Sciences, Cell Biology, Developmental Biology +13

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Katarina Le Blanc, Ida Rasmusson, Berit Sundberg et al. · The Lancet · 2004 · 2.7K citations

Life Sciences, Immunology, Surgery +12

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Katarina Le Blanc, Francesco Frassoni, Lynne M. Ball et al. · The Lancet · 2008 · 2.7K citations

Life Sciences, Immunology, Regenerative Medicine +11

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

E.M. Horwitz, Katarina Le Blanc, Massimo Dominici et al. · Cytotherapy · 2005 · 2K citations

Pharmacy, Biomedical Engineering, Cell Biology +13

Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting

Oscar P. B. Wiklander, Joel Z. Nordin, Aisling J. O’Loughlin et al. · Journal of Extracellular Vesicles · 2015 · 1.7K citations · Full text

Pharmacy, Cell Biology, Pharmaceutics +15